Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (14)

2024

  1. Opportunistic population screening as a hepatitis elimination strategy: the CRIVALVIR-FOCUS program

    International Journal of Infectious Diseases, Vol. 146

  2. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

2023

  1. Outcomes of an automated alert system from Microbiology to link diagnosis to treatment in patients with hepatitis C virus

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 4, pp. 181-187

2022

  1. Assessment of liver damage in patients with COVID-19 is sub-optimal: results of a survey of medical practitioners

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva

  2. One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infection

    Annals of Hepatology, Vol. 27, Núm. 1

2021

  1. Abnormal liver chemistry constitutes an independent prognostic factor of less favorable clinical course in patients with COVID-19

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 113, Núm. 12, pp. 825-832

  2. Can secukinumab improve liver fibrosis? A pilot prospective study of 10 psoriatic patients

    Dermatologic Therapy

2020

  1. Hepatic encephalopathy due to a congenital portosystemic shunt: A disease with a changeable presentation

    Revista Espanola de Enfermedades Digestivas

  2. Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate–severe psoriasis: A cross-sectional cohort study

    Australasian Journal of Dermatology, Vol. 61, Núm. 2, pp. 105-109

2017

  1. Gastrointestinal bleeding and acute hepatic failure by leptospirosis: an entity that should not be forgotten

    Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, Vol. 37, Núm. 1, pp. 96-99

2011

  1. SUBANALYSES OF THE TELAPREVIR LEAD-IN ARM IN THE REALIZE STUDY: RESPONSE AT WEEK 4 IS NOT A SUBSTITUTE FOR PRIOR NULL RESPONSE CATEGORIZATION

    SWISS MEDICAL WEEKLY

  2. Telaprevir-based therapy in G1 HCV-infected patients with prior null response, partial response or relapse to peginterferon/ribavirin: REALIZE trial final results

    SWISS MEDICAL WEEKLY

2006

  1. Tratamiento de pacientes genotipo 4

    Gastroenterologia y Hepatologia

2005

  1. Rentabilidad de la ecografía abdominal en el diagnóstico del carcinoma colorrectal

    Revista Espanola de Enfermedades Digestivas